Cover Image

K‐means clustering‐based analysis of quantitative ultrafast DCE‐MRI for predicting breast cancer response to neoadjuvant chemotherapy

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Zhen Ren, Xiaobing Fan, Milica Medved, Frederick M. Howard, Rita Nanda, Hiroyuki Abe, Kirti Kulkarni, Anna Biernacka, Nan Chen, Gregory S. Karczmar
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Journal of Applied Clinical Medical Physics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Introduction to matrix‐based method for analyzing hybrid multidimensional prostate MRI data
by: Xiaobing Fan, et al.
Published: (2024)

To deform or not: treatment-aware longitudinal registration for breast DCE-MRI during neoadjuvant chemotherapy via unsupervised keypoints detection
by: Han, Luyi, et al.
Published: (2024)

Self‐supervised multicontrast super‐resolution for diffusion‐weighted prostate MRI
by: Batuhan Gundogdu, et al.
Published: (2024)

The contrast‐free diffusion MRI multiple index for the early prediction of pathological response to neoadjuvant chemotherapy in breast cancer
by: Lina Zhang, et al.
Published: (2024)

Digital reference object toolkit of breast DCE MRI for quantitative evaluation of image reconstruction and analysis methods
by: Jonghyun Bae, et al.
Published: (2024)

An ultrasound‐based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation
by: Qijun Zheng, et al.
Published: (2024)

Real world study of pertuzumab-trastuzumab-chemotherapy versus trastuzumab-chemotherapy in neoadjuvant treatment of breast cancer
by: Rocío Díaz-Acedo
Published: (2020)

Exploring the added value of pretherapeutic MR descriptors in predicting breast cancer pathologic complete response to neoadjuvant chemotherapy
by: Malhaire, Caroline, et al.
Published: (2025)

Integrating multiparametric MRI radiomics and clinical models to assess sensitivity to neoadjuvant chemotherapy in breast cancer: A multicenter study
by: Xinyi Zeng, et al.
Published: (2025)

Clinicopathologic and molecular correlates to neoadjuvant chemotherapy‐induced pathologic response in breast angiosarcoma
by: Hsin‐Yi Chang, et al.
Published: (2024)

Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis
by: Shaoji Zhao, et al.
Published: (2024)

A randomized controlled study of neoadjuvant metformin with chemotherapy in nondiabetic breast cancer women: The METNEO study
by: Manar A. Serageldin, et al.
Published: (2024)

A large-scale multicenter breast cancer DCE-MRI benchmark dataset with expert segmentations
by: Garrucho, Lidia, et al.
Published: (2024)

DCE-Qnet: Deep Network Quantification of Dynamic Contrast Enhanced (DCE) MRI
by: Cohen, Ouri, et al.
Published: (2024)

Experts' cognition-driven ensemble deep learning for external validation of predicting pathological complete response to neoadjuvant chemotherapy from histological images in breast cancer
by: Yang, Yongquan, et al.
Published: (2023)

Retesting of oestrogen receptor, progesterone receptor and HER2 status of invasive carcinoma of the breast after neoadjuvant chemotherapy
by: Andrew H S Lee, et al.
Published: (2025)

Dual-attention ResNet outperforms transformers in HER2 prediction on DCE-MRI
by: Fridman, Naomi, et al.
Published: (2025)

Prognostic impact of shift to low visceral fat mass after neoadjuvant chemotherapy in patients with esophageal cancer
by: Sachiyo Onishi, et al.
Published: (2024)

Palbociclib in breast cancer neoadjuvant setting
by: Sílvia Alexandra Cabral Duarte
Published: (2021)

Long‐term outcomes and risk profile of cT3N0 breast cancer treated with neoadjuvant chemotherapy and curative surgery
by: Young Seob Shin, et al.
Published: (2024)

Toward a robust lesion detection model in breast DCE-MRI: adapting foundation models to high-risk women
by: Nascimento, Gabriel A. B. do, et al.
Published: (2025)

Identifying radiogenomic associations of breast cancer based on DCE‐MRI by using Siamese Neural Network with manufacturer bias normalization
by: Junhua Chen, et al.
Published: (2024)

Addition of neoadjuvant chemotherapy to a ‘quadrifecta’ composite in radical cystectomy
by: David D’Andrea, et al.
Published: (2024)

Breast Cancer: Habitat imaging based on intravoxel incoherent motion for predicting pathologic complete response to neoadjuvant chemotherapy
by: Hui Zhang, et al.
Published: (2025)

Sławomir Czech, 2019, Od konfliktu do kooperacji. Instytucjonalizacja konfliktu interesów zbiorowych w szwedzkim modelu gospodarczym, Warszawa: Wydawnictwo Naukowe Scholar
by: Maja Biernacka
Published: (2020)

Efficacy and safety of dose‐dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle‐invasive bladder cancer
by: Yuto Hattori, et al.
Published: (2024)

A two-stage dual-task learning strategy for early prediction of pathological complete response to neoadjuvant chemotherapy for breast cancer using dynamic contrast-enhanced magnetic resonance images
by: Jing, Bowen, et al.
Published: (2025)

The efficacy of neoadjuvant immunotherapy combined with chemotherapy in elderly patients with gastric cancer: A subgroup analysis of the NEOSUMMIT‐01 study
by: Nan An, et al.
Published: (2024)

Utilization and survival outcomes of neoadjuvant chemotherapy for early‐stage gastric cancer
by: Lauren M. Janczewski, et al.
Published: (2024)

Dynamic contrast enhanced‐magnetic resonance fingerprinting (DCE‐MRF): A new quantitative MRI method to reliably assess tumor vascular perfusion
by: Christina J. MacAskill, et al.
Published: (2025)

The prevalence and clinical significance of residual occult breast cancer after neoadjuvant chemotherapy: reassessing surgical pathology in cases initially described as pathological complete response
by: Di Ai, et al.
Published: (2025)

Can FDG‐PET after neoadjuvant chemotherapy plus nivolumab predict residual disease in non‐small cell lung cancer?
by: Hideto Iguchi, et al.
Published: (2024)

Docetaxel, cisplatin, and fluorouracil with pegfilgrastim on day 3 as neoadjuvant chemotherapy for esophageal cancer
by: Osamu Maeda, et al.
Published: (2024)

Comparing DCE‐MRI and DSA: Understanding the embolization of hypervascular spinal metastases
by: Muhammad Adnan, et al.
Published: (2024)

Improving DCE-MRI through unfolded low-rank + sparse optimisation
by: Mokrý, Ondřej, et al.
Published: (2023)

Optimizing treatment sequence for inoperable locally advanced breast cancer: Long‐term outcomes of surgery first versus neoadjuvant chemotherapy in a real‐world setting
by: Bowen Liu, et al.
Published: (2024)

Impact of intra‐tumoral immunity on predicting response and survival after neoadjuvant cisplatin‐based chemotherapy in patients with muscle invasive bladder cancer
by: Alberto Mendoza‐Valderrey, et al.
Published: (2024)

Promising biomarker panel to monitor therapeutic efficacy of neoadjuvant chemotherapy in pancreatic cancer patients
by: Josef E. Gillson, et al.
Published: (2024)

Human tumour vessel heterogeneity in ovarian cancer and its association with response to neoadjuvant chemotherapy
by: Emmanuel M. Gabriel, et al.
Published: (2024)

Response to neoadjuvant chemotherapy leads to better survival outcomes in upper tract urothelial carcinoma
by: Alice Yu, et al.
Published: (2025)